All Cosmos Bio-Tech Holding Corporation (4148.TW)
TWD 45.55
(-1.83%)
TWD 45.55
(-1.83%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 958.86 Million | 43.84 Million | -67.64 Million | -126.87 Million | 883.55 Million | -218.33 Million |
| Net Income | 139.36 Million | 633.95 Million | 321.58 Million | 149.67 Million | 103.81 Million | 399.01 Million |
| Depreciation & Amortization | 49.14 Million | 49.01 Million | 48.59 Million | 50.15 Million | 53.24 Million | 46.21 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 796.33 Million | -498.38 Million | -358.79 Million | -274.97 Million | 737.63 Million | -611.31 Million |
| Other non-cash items | -25.97 Million | -140.73 Million | -79.02 Million | -51.73 Million | -11.13 Million | -52.25 Million |
| Investing Cash Flow | -170.48 Million | -4.66 Million | -108.16 Million | 131.6 Million | -284.31 Million | -93.24 Million |
| Investments in PPE | -163.42 Million | -60.85 Million | -103.84 Million | -35.18 Million | -39.2 Million | -59.52 Million |
| Acquisitions | 62.45 Million | -13.5 Million | -136 Thousand | 6.02 Million | 1.41 Million | -16.88 Million |
| Investment purchases | -111.16 Million | -36.95 Million | -71.52 Million | -6.02 Million | -232.99 Million | -3.19 Million |
| Sales/Maturities of investments | 34.12 Million | 106.72 Million | 66.86 Million | 169.48 Million | 9.4 Million | -1.95 Million |
| Other Investing Activities | 7.51 Million | -76 Thousand | 479 Thousand | -2.69 Million | -22.93 Million | -11.68 Million |
| Financing Cash Flow | -582.37 Million | 490.38 Million | 196.09 Million | -46.09 Million | -344.34 Million | -93.99 Million |
| Debt repayment | -396.11 Million | -1.28 Billion | -461.27 Million | -23.8 Million | -172.28 Million | -23 Million |
| Dividends payments | -160.08 Million | -96.05 Million | -64.03 Million | -64.03 Million | -153.68 Million | -169.69 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -26.17 Million | 1.87 Billion | 721.41 Million | 41.74 Million | -18.38 Million | 98.7 Million |
| Accounts receivables | 249.25 Million | -233.48 Million | 138.51 Million | -211.18 Million | 439.84 Million | -296.74 Million |
| Accounts payables | 47.97 Million | -21.7 Million | 3.4 Million | -7.01 Million | 27.58 Million | 9 Million |
| Inventory | 537.7 Million | -250.48 Million | -598.1 Million | 10.14 Million | 311.3 Million | -372.08 Million |
| Other working capital | -38.59 Million | 7.28 Million | 97.39 Million | -66.9 Million | -41.09 Million | -239.22 Million |
| Cash at beginning of period | 1.34 Billion | 740.43 Million | 761.8 Million | 837.59 Million | 591.5 Million | 993.82 Million |
| Cash at end of period | 1.54 Billion | 1.34 Billion | 740.43 Million | 761.8 Million | 837.59 Million | 591.5 Million |
| Capital Expenditure | -163.42 Million | -60.85 Million | -103.84 Million | -35.18 Million | -39.2 Million | -59.52 Million |
| Effect of forex changes on cash | -89.02 Million | 71.5 Million | -41.65 Million | -34.41 Million | -8.8 Million | 3.24 Million |
| Net cash flow / Change in cash | 203.38 Million | 601.07 Million | -21.36 Million | -75.78 Million | 246.08 Million | -402.32 Million |
| Free Cash Flow | 795.44 Million | -17.01 Million | -171.49 Million | -162.06 Million | 844.35 Million | -277.85 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 28.33 Million | 28.48 Million | -8.54 Million | 139.36 Million | 117.98 Million | 34.73 Million |
| Depreciation & Amortization | 13.24 Million | 12.35 Million | 13.24 Million | 49.14 Million | 12.94 Million | 11.6 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -46.94 Million | 3.88 Million | -39.77 Million | 796.33 Million | 387.36 Million | 165.67 Million |
| Other non-cash items | -10.78 Million | 30.75 Million | 27.73 Million | -25.97 Million | -47.25 Million | -53.13 Million |
| Investing Cash Flow | -62.67 Million | -161.64 Million | -14.92 Million | -170.48 Million | -93.34 Million | -87.61 Million |
| Investments in PPE | -32.12 Million | -71.16 Million | -53.01 Million | -163.42 Million | -22.09 Million | -77.26 Million |
| Acquisitions | 2.85 Million | 540 Thousand | 32.48 Million | 62.45 Million | 55 Thousand | 29.84 Million |
| Investment purchases | -43.31 Million | -91.09 Million | 183 Thousand | -111.16 Million | -70.26 Million | -41.08 Million |
| Sales/Maturities of investments | 10.11 Million | - | -93 Thousand | 34.12 Million | 614 Thousand | -799 Thousand |
| Other Investing Activities | -200 Thousand | 75 Thousand | 5.51 Million | 7.51 Million | -1.65 Million | 1.69 Million |
| Financing Cash Flow | -13.1 Million | 14.5 Million | -2.68 Million | -582.37 Million | -163.79 Million | -19.74 Million |
| Debt repayment | -4.84 Million | -15.82 Million | -1.37 Million | -396.11 Million | -2.4 Million | -1.47 Million |
| Dividends payments | - | - | - | -160.08 Million | -160.08 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -16.6 Million | -11 Thousand | -1.31 Million | -26.17 Million | -1.3 Million | -18.27 Million |
| Accounts receivables | 37.49 Million | -44.59 Million | 94.7 Million | 249.25 Million | 256 Million | -65.23 Million |
| Accounts payables | 11.75 Million | -44.36 Million | -180.79 Million | 47.97 Million | 243.35 Million | -305.01 Million |
| Inventory | -78.74 Million | 102 Million | 40.21 Million | 537.7 Million | -79.25 Million | 522.26 Million |
| Other working capital | -17.45 Million | -9.17 Million | 6.09 Million | -38.59 Million | -32.73 Million | 13.66 Million |
| Cash at beginning of period | 1.39 Billion | 1.54 Billion | 1.59 Billion | 1.34 Billion | 1.27 Billion | 1.27 Billion |
| Cash at end of period | 1.31 Billion | 1.52 Billion | 1.54 Billion | 1.54 Billion | 1.5 Billion | 1.27 Billion |
| Capital Expenditure | -32.12 Million | -71.16 Million | -53.01 Million | -163.42 Million | -22.09 Million | -77.26 Million |
| Effect of forex changes on cash | 20.54 Million | 21.34 Million | -23.82 Million | -89.02 Million | 22.66 Million | -55.77 Million |
| Net cash flow / Change in cash | -86.96 Million | -23.62 Million | -50.22 Million | 203.38 Million | 236.56 Million | -4.24 Million |
| Free Cash Flow | -63.85 Million | -7.34 Million | -60.36 Million | 795.44 Million | 448.94 Million | 81.62 Million |
COP
VDKB
ASMS
TOMYY
1SN
UNIPARTS